망막박리 치료 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 치료법별, 질환별, 연령대별, 최종 용도별, 지역별 및 부문별 전망(2026-2033년)

Retinal Detachment Treatment Market Summary

The global retinal detachment treatment market size was valued at USD 166.1 million in 2025 and is projected to grow from USD 171.4 million in 2026 to USD 214.7 million by 2033, at a CAGR of 3.3% from 2026 to 2033. Europe dominated the market, accounting for the revenue share of 42.6% in 2025. The growth is supported by the continuing clinical burden of rhegmatogenous retinal detachment (RRD), an acute sight-threatening condition that requires timely diagnosis and treatment to prevent permanent vision loss.

RRD is the most common form of retinal detachment and is associated with factors such as increasing age, myopia, previous ocular surgery, and ocular trauma. The market encompasses a range of surgical procedures and supporting technologies used to restore retinal attachment and preserve vision in patients with retinal detachment. Treatment selection depends on the type, location, and extent of detachment and may include PPV, scleral buckling, pneumatic retinopexy, and combined procedures. These approaches require a combination of specialized instruments and visualization technologies to allow surgeons to identify retinal breaks, remove vitreous traction, drain subretinal fluid, apply laser photocoagulation, and introduce intraocular tamponade when required.

Light guides are an important illumination component used during vitreoretinal surgery, particularly pars plana vitrectomy, performed to repair retinal detachment. These fiber-optic devices deliver light inside the eye, allowing surgeons to clearly visualize the retina, vitreous, retinal tears, and other structures during surgery. Depending on the procedure, light guides can provide focused, widefield, or midfield illumination. The availability of different gauge sizes, including 20G, 23G, 25G, 27G, and smaller sizes, supports their use in various minimally invasive retinal procedures. Bausch + Lomb, for example, offers multiple endoillumination options and fiber-optic accessories for retinal detachment procedures.

The growing adoption of minimally invasive vitrectomy is a major factor supporting demand for light guides. As retinal surgeons increasingly use small-gauge instruments, illumination systems must provide sufficient light through smaller surgical access points without compromising visualization. Recent clinical guidance also emphasizes that appropriate illumination is critical during retinal detachment surgery.

Population aging is a major driver of demand for retinal detachment treatment. According to Eurostat, people aged 65 years and older accounted for 22.0% of the EU population in 2025, up from 21.6% in 2024. Retinal detachment is particularly relevant in older adults because the incidence of RRD tends to peak in the sixth and seventh decades of life, often in association with age-related posterior vitreous detachment. The expanding older population, therefore, increases the number of individuals who require retinal examinations, diagnoses, and treatment for retinal tears and detachments. The increasing volume of cataract surgeries is expected to further support demand for retinal detachment treatment across Europe.

Global Retinal Detachment Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global retinal detachment treatment market report based on product, treatment, disease, age group, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Light Guides
• Chandelier Systems
• Binocular Inverting Loupes
• Other Devices
• Treatment Outlook (Revenue, USD Million, 2021 - 2033)
• Scleral Buckling/Scleral Indentation
• Pars Plana Vitrectomy
• Pneumatic Retinopexy
• Combined Treatments
• Other Treatment
• Disease Outlook (Revenue, USD Million, 2021 - 2033)
• Rhegmatogenous Retinal Detachment (RRD)
• Tractional Retinal Detachment (TRD)
• Exudative/Serous Retinal Detachment
• Tractional-Rhegmatogenous Retinal Detachment (TRD-RRD)
• Others
• Age Group Outlook (Revenue, USD Million, 2021 - 2033)
• Pediatric
• Adult
• Geriatric
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Inpatient Facilities
• Outpatient Facilities
• Region Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
• Asia Pacific
  • China
  • Japan
  • South Korea
  • Thailand
  • Australia
  • India
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Treatment
  • 1.2.3. Disease
  • 1.2.4. Age Group
  • 1.2.5. End Use
  • 1.2.6. Regional scope
  • 1.2.7. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product Outlook
  • 2.2.2. Treatment Outlook
  • 2.2.3. Disease Outlook
  • 2.2.4. Age Group Outlook
  • 2.2.5. End Use Outlook
  • 2.2.6. Regional Outlook
• 2.3. Competitive Insights

Chapter 3. Retinal Detachment Treatment Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Retinal Detachment Treatment Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Retinal Detachment Treatment Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Retinal Detachment Treatment Market: Product Movement Analysis
• 4.3. Retinal Detachment Treatment Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. Light Guides
  • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Chandelier Systems
  • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Binocular Inverting Loupes
  • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Other Devices
  • 4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Retinal Detachment Treatment Market: Treatment Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Retinal Detachment Treatment Market: Treatment Movement Analysis
• 5.3. Retinal Detachment Treatment Market by Treatment Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. Scleral Buckling/Scleral Indentation
  • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Pars Plana Vitrectomy
  • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Pneumatic Retinopexy
  • 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Combined Procedures
  • 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. Other Treatments
  • 5.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Retinal Detachment Treatment Market: Disease Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Retinal Detachment Treatment Market: Disease Movement Analysis
• 6.3. Retinal Detachment Treatment Market by Disease Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. Rhegmatogenous Retinal Detachment (RRD)
  • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Tractional Retinal Detachment (TRD)
  • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Exudative/Serous Retinal Detachment
  • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Tractional-Rhegmatogenous Retinal Detachment (TRD-RRD)
  • 6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.9. Others
  • 6.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Retinal Detachment Treatment Market: Age Group Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Retinal Detachment Treatment Market: Age Group Movement Analysis
• 7.3. Retinal Detachment Treatment Market by Age Group Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 7.5. Pediatric
  • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Adult
  • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Geriatric
  • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Retinal Detachment Treatment Market: End Use Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Retinal Detachment Treatment Market: End Use Movement Analysis
• 8.3. Retinal Detachment Treatment Market, By End Use Outlook (USD Million)
• 8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 8.5. Inpatient Facilities
  • 8.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Outpatient Facilities
  • 8.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Retinal Detachment Treatment Market: Regional Estimates & Trend Analysis

• 9.1. Regional Dashboard
• 9.2. Regional Retinal Detachment Treatment Market Movement Analysis
• 9.3. Retinal Detachment Treatment Market: Regional Estimates & Trend Analysis by Product & Treatment
• 9.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 9.5. North America
  • 9.5.1. North America Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.2. U.S.
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Competitive Scenario
    • 9.5.2.3. Regulatory Framework
    • 9.5.2.4. Reimbursement scenario
    • 9.5.2.5. U.S. Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.3. Canada
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Competitive Scenario
    • 9.5.3.3. Regulatory Framework
    • 9.5.3.4. Reimbursement scenario
    • 9.5.3.5. Canada Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.4. Mexico
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Competitive Scenario
    • 9.5.4.3. Regulatory Framework
    • 9.5.4.4. Reimbursement scenario
    • 9.5.4.5. Mexico Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.6. Europe
  • 9.6.1. Europe Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.2. UK
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Competitive Scenario
    • 9.6.2.3. Regulatory Framework
    • 9.6.2.4. Reimbursement scenario
    • 9.6.2.5. UK Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.3. Germany
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Competitive Scenario
    • 9.6.3.3. Regulatory Framework
    • 9.6.3.4. Reimbursement scenario
    • 9.6.3.5. Germany Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.4. France
    • 9.6.4.1. Key Country Dynamics
    • 9.6.4.2. Competitive Scenario
    • 9.6.4.3. Regulatory Framework
    • 9.6.4.4. Reimbursement scenario
    • 9.6.4.5. France Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.5. Italy
    • 9.6.5.1. Key Country Dynamics
    • 9.6.5.2. Competitive Scenario
    • 9.6.5.3. Regulatory Framework
    • 9.6.5.4. Reimbursement scenario
    • 9.6.5.5. Italy Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.6. Spain
    • 9.6.6.1. Key Country Dynamics
    • 9.6.6.2. Competitive Scenario
    • 9.6.6.3. Regulatory Framework
    • 9.6.6.4. Reimbursement scenario
    • 9.6.6.5. Spain Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.7. Denmark
    • 9.6.7.1. Key Country Dynamics
    • 9.6.7.2. Competitive Scenario
    • 9.6.7.3. Regulatory Framework
    • 9.6.7.4. Reimbursement scenario
    • 9.6.7.5. Denmark Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.8. Sweden
    • 9.6.8.1. Key Country Dynamics
    • 9.6.8.2. Competitive Scenario
    • 9.6.8.3. Regulatory Framework
    • 9.6.8.4. Reimbursement scenario
    • 9.6.8.5. Sweden Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.9. Norway
    • 9.6.9.1. Key Country Dynamics
    • 9.6.9.2. Competitive Scenario
    • 9.6.9.3. Regulatory Framework
    • 9.6.9.4. Reimbursement scenario
    • 9.6.9.5. Norway Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.7. Asia Pacific
  • 9.7.1. Asia Pacific Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.2. Japan
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Competitive Scenario
    • 9.7.2.3. Regulatory Framework
    • 9.7.2.4. Reimbursement scenario
    • 9.7.2.5. Japan Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.3. China
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Competitive Scenario
    • 9.7.3.3. Regulatory Framework
    • 9.7.3.4. Reimbursement scenario
    • 9.7.3.5. China Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.4. India
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. Competitive Scenario
    • 9.7.4.3. Regulatory Framework
    • 9.7.4.4. Reimbursement scenario
    • 9.7.4.5. India Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.5. South Korea
    • 9.7.5.1. Key Country Dynamics
    • 9.7.5.2. Competitive Scenario
    • 9.7.5.3. Regulatory Framework
    • 9.7.5.4. Reimbursement scenario
    • 9.7.5.5. South Korea Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.6. Australia
    • 9.7.6.1. Key Country Dynamics
    • 9.7.6.2. Competitive Scenario
    • 9.7.6.3. Regulatory Framework
    • 9.7.6.4. Reimbursement scenario
    • 9.7.6.5. Australia Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.7. Thailand
    • 9.7.7.1. Key Country Dynamics
    • 9.7.7.2. Competitive Scenario
    • 9.7.7.3. Regulatory Framework
    • 9.7.7.4. Reimbursement scenario
    • 9.7.7.5. Thailand Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.8. Latin America
  • 9.8.1. Latin America Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.8.2. Brazil
    • 9.8.2.1. Key Country Dynamics
    • 9.8.2.2. Competitive Scenario
    • 9.8.2.3. Regulatory Framework
    • 9.8.2.4. Reimbursement scenario
    • 9.8.2.5. Brazil Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.8.3. Argentina
    • 9.8.3.1. Key Country Dynamics
    • 9.8.3.2. Competitive Scenario
    • 9.8.3.3. Regulatory Framework
    • 9.8.3.4. Reimbursement scenario
    • 9.8.3.5. Argentina Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.9. Middle East & Africa
  • 9.9.1. Middle East & Africa Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.9.2. South Africa
    • 9.9.2.1. Key Country Dynamics
    • 9.9.2.2. Competitive Scenario
    • 9.9.2.3. Regulatory Framework
    • 9.9.2.4. Reimbursement scenario
    • 9.9.2.5. South Africa Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.9.3. Saudi Arabia
    • 9.9.3.1. Key Country Dynamics
    • 9.9.3.2. Competitive Scenario
    • 9.9.3.3. Regulatory Framework
    • 9.9.3.4. Reimbursement scenario
    • 9.9.3.5. Saudi Arabia Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.9.4. UAE
    • 9.9.4.1. Key Country Dynamics
    • 9.9.4.2. Competitive Scenario
    • 9.9.4.3. Regulatory Framework
    • 9.9.4.4. Reimbursement scenario
    • 9.9.4.5. UAE Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.9.5. Kuwait
    • 9.9.5.1. Key Country Dynamics
    • 9.9.5.2. Competitive Scenario
    • 9.9.5.3. Regulatory Framework
    • 9.9.5.4. Reimbursement scenario
    • 9.9.5.5. Kuwait Retinal Detachment Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Market Participant Categorization
• 10.2. Key Company Profiles
  • 10.2.1. Alcon
    • 10.2.1.1. Company Overview
    • 10.2.1.2. Financial Performance
    • 10.2.1.3. Product Benchmarking
    • 10.2.1.4. Strategic Initiatives
  • 10.2.2. ZEISS
    • 10.2.2.1. Company Overview
    • 10.2.2.2. Financial Performance
    • 10.2.2.3. Product Benchmarking
    • 10.2.2.4. Strategic Initiatives
  • 10.2.3. Bausch Health
    • 10.2.3.1. Company Overview
    • 10.2.3.2. Financial Performance
    • 10.2.3.3. Product Benchmarking
    • 10.2.3.4. Strategic Initiatives
  • 10.2.4. Topcon Corporation
    • 10.2.4.1. Company Overview
    • 10.2.4.2. Financial Performance
    • 10.2.4.3. Product Benchmarking
    • 10.2.4.4. Strategic Initiatives
  • 10.2.5. NIDEK Co., Ltd.
    • 10.2.5.1. Company Overview
    • 10.2.5.2. Financial Performance
    • 10.2.5.3. Product Benchmarking
    • 10.2.5.4. Strategic Initiatives
  • 10.2.6. OCULUS Optikgerate GmbH
    • 10.2.6.1. Company Overview
    • 10.2.6.2. Financial Performance
    • 10.2.6.3. Product Benchmarking
    • 10.2.6.4. Strategic Initiatives
  • 10.2.7. Oertli Instrumente AG
    • 10.2.7.1. Company Overview
    • 10.2.7.2. Financial Performance
    • 10.2.7.3. Product Benchmarking
    • 10.2.7.4. Strategic Initiatives
  • 10.2.8. BVI
    • 10.2.8.1. Company Overview
    • 10.2.8.2. Financial Performance
    • 10.2.8.3. Product Benchmarking
    • 10.2.8.4. Strategic Initiatives
  • 10.2.9. Haag-Streit Group
    • 10.2.9.1. Company Overview
    • 10.2.9.2. Financial Performance
    • 10.2.9.3. Product Benchmarking
    • 10.2.9.4. Strategic Initiatives
  • 10.2.10. Leica Microsystems
    • 10.2.10.1. Company Overview
    • 10.2.10.2. Financial Performance
    • 10.2.10.3. Product Benchmarking
    • 10.2.10.4. Strategic Initiatives